MSLN STAR-T cells therapy (China Immunotech Co Ltd)

N/A

Report date: 2022/07/22 16:26:06

Base Information

Drug NameMSLN STAR-T cells therapy (China Immunotech Co Ltd)

Drug Alias NameMSLN STAR-T cellsYTS-105

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsAnti-Mesothelin

TargetsMesothelin

Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms, Mesothelial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChina Immunotech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChina Immunotech Co Ltd

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsNeoplasms, Mesothelial

Inactive IndicationsN/A

Other Information

ATC CodeN/A